血管与腔内血管外科杂志最新文献_第7页

A simple technique to facilitate antegrade thoracic endograft deployment using a hybrid elephant trunk procedure under hypothermic circulatory arrest. 在低温循环停止下使用混合象鼻手术促进顺行胸腔内移植物部署的简单技术。

血管与腔内血管外科杂志 Pub Date : 2007-01-01 DOI: 10.1583/1545-1550(2007)14[669:asttfa]2.0.co;2

P. Lin, A. Dardik, J. Coselli

引用次数: 1

Targeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: results of a feasibility pilot trial. 血管内腹主动脉瘤修复过程中的靶向肾治疗和造影剂肾病:一项可行性试点试验的结果。

血管与腔内血管外科杂志 Pub Date : 2007-01-01 DOI: 10.1583/1545-1550(2007)14[520:trtacn]2.0.co;2

D. Allie, M. Lirtzman, C. H. Wyatt, V. A. Keller, Elena V. Mitran, C. Hebert, R. Patlola, Kalyan K. Veerina, C. Walker

{"title":"Targeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: results of a feasibility pilot trial.","authors":"D. Allie, M. Lirtzman, C. H. Wyatt, V. A. Keller, Elena V. Mitran, C. Hebert, R. Patlola, Kalyan K. Veerina, C. Walker","doi":"10.1583/1545-1550(2007)14[520:trtacn]2.0.co;2","DOIUrl":"https://doi.org/10.1583/1545-1550(2007)14[520:trtacn]2.0.co;2","url":null,"abstract":"PURPOSE To evaluate the feasibility of targeted renal therapy (TRT) to decrease the rate of contrast-induced nephropathy (CIN) during endovascular aortic aneurysm repair (EVAR) in patients at risk for CIN. METHODS A prospective nonrandomized analysis of TRT was performed in 10 high-risk patients (8 men; median age 66.5 years, range 56-80) with pre-existing renal insufficiency. TRT involved high-dose intrarenal artery infusions of fenoldopam (FEN), a short acting selective dopamine-1 agonist and renal arteriolar vasodilator, delivered percutaneously via a left brachial access using the 5-F Benephit PV Infusion System during EVAR. RESULTS There were no device-related complications. TRT infusion duration ranged from 3.5 to 6.0 hours (median 4.5). Median contrast dosage was 120 mL (range 50-200). At 24 and 72 hours after EVAR, creatinine clearance (CrCl) had improved in 7 (70%) patients, remained unchanged in 2 (20%), and declined >25% in 1 (10%); the latter returned to baseline on day 5. At 30 days, 7 (70%) patients had improved CrCl and 3 (30%) remained unchanged. CONCLUSION TRT is feasible during EVAR in high-risk patients. Further investigation is warranted to determine the safety and efficacy of TRT in preserving renal function during EVAR.","PeriodicalId":60152,"journal":{"name":"血管与腔内血管外科杂志","volume":"50 1","pages":"520-7"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85175970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 11

Infrainguinal lesion-specific device choices: round-table discussion. 针对腹股沟下病变的器械选择:圆桌讨论。

血管与腔内血管外科杂志 Pub Date : 2006-02-01 DOI: 10.1583/05-1758.1

T. Das, J. Beregi, L. Garcia, Omran R Abul-Khoudoud, J. Laird, A. Lumsden, S. Lyden, M. Mewissen, T. Shimshak

引用次数: 4

Diagnosis and risk assessment of lower extremity peripheral arterial disease. 下肢外周动脉疾病的诊断与风险评估。

血管与腔内血管外科杂志 Pub Date : 2006-02-01 DOI: 10.1583/05-1752.1

Omran R Abul-Khoudoud

引用次数: 26

Endovascular management of infrainguinal disease. 腹股沟下疾病的血管内治疗。

血管与腔内血管外科杂志 Pub Date : 2006-02-01 DOI: 10.1583/05-17XX.1

A. Lumsden, T. Das

引用次数: 9

Epidemiology and pathophysiology of lower extremity peripheral arterial disease. 下肢外周动脉疾病的流行病学和病理生理学。

血管与腔内血管外科杂志 Pub Date : 2006-02-01 DOI: 10.1583/05-1751.1

L. Garcia

{"title":"Epidemiology and pathophysiology of lower extremity peripheral arterial disease.","authors":"L. Garcia","doi":"10.1583/05-1751.1","DOIUrl":"https://doi.org/10.1583/05-1751.1","url":null,"abstract":"Peripheral arterial disease (PAD), a major cause of disability, loss of work, and lifestyle changes in the United States, is defined as obstruction of blood flow into an arterial tree excluding the intracranial or coronary circulations. PAD is mostly silent in its early stages, but when lesion obstruction exceeds 50%, it may cause intermittent claudication with ambulation. Further disease progression typically leads to rest pain or frank tissue loss. However, some patients may remain asymptomatic with severe disease because of extensive collateralization in the lower extremity. Estimates of the prevalence of intermittent claudication vary by population, from 0.6% to nearly 10%; the rate increases dramatically with age. Approximately 20% to 25% of patients will require revascularization, while fewer than 5% will progress to critical limb ischemia. Limb loss, although rare, is associated with severe disability and an overall poor prognosis, with 30% to 40% mortality in the first 24 months after limb loss. As with coronary artery disease, the most common cause of symptomatic obstruction in the peripheral arterial tree is atherosclerosis, a systemic inflammatory process in which cholesterol-laden plaque builds up in the artery and eventually blocks the lumen. Typical risk factors include age, gender, diabetes, tobacco abuse, hypertension, and hyperlipidemia.","PeriodicalId":60152,"journal":{"name":"血管与腔内血管外科杂志","volume":"205 1","pages":"II3-9"},"PeriodicalIF":0.0,"publicationDate":"2006-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77219053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 107

Contemporary endovascular treatment for disease of the superficial femoral and popliteal arteries: an integrated device-based strategy. 当代股浅动脉和腘动脉疾病的血管内治疗:一种基于器械的综合策略。

血管与腔内血管外科杂志 Pub Date : 2006-02-01 DOI: 10.1583/05-1757.1

S. Lyden, T. Shimshak

{"title":"Contemporary endovascular treatment for disease of the superficial femoral and popliteal arteries: an integrated device-based strategy.","authors":"S. Lyden, T. Shimshak","doi":"10.1583/05-1757.1","DOIUrl":"https://doi.org/10.1583/05-1757.1","url":null,"abstract":"Endovascular therapy for disease of the superficial femoral artery (SFA) and the popliteal artery remains controversial. Percutaneous treatment of this arterial segment presents a particular technical challenge, as the extent of disease varies from short, focal, and stenotic to long, diffuse, and occluded lesions. Over the last 2 decades, multiple therapies have been evaluated, including simple balloon angioplasty, directional atherectomy, stenting (both balloon-expandable and self-expanding), and more recently, intra-arterial radiation, laser, and cryotherapy. Regardless of which modality is used, however, endovascular therapy as a revascularization strategy has the potential to improve symptoms and quality of life and, in selected patients, to avoid limb amputation. While percutaneous endovascular treatment has been historically associated with high procedural success and favorable short and intermediate-term patency rates, long-term clinical results have proven disappointing. Conventional balloon angioplasty is limited by elastic recoil, dissection, and restenosis. Balloon-expandable stents (particularly in the distal SFA) are associated with late stent deformation and mechanical compression, with resultant late clinical failure. Newer self-expanding stents have shown improved initial results but have been limited by late mechanical fatigue and associated restenosis. With the development of several newer endovascular techniques in recent years, the possibilities for treating this condition have increased dramatically. Currently, no long-term comparative data exist regarding the role of these alternative technologies. This article summarizes and compares important data about new endovascular options for intervention therapy in SFA and popliteal disease. In addition, based on this analysis, we propose a contemporary treatment strategy, integrating older and newer technologies into a real-world algorithm.","PeriodicalId":60152,"journal":{"name":"血管与腔内血管外科杂志","volume":"13 Suppl 2 1","pages":"II41-51"},"PeriodicalIF":0.0,"publicationDate":"2006-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79046805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 22

Medical management of peripheral arterial disease: a therapeutic algorithm. 外周动脉疾病的医疗管理:一种治疗算法。

血管与腔内血管外科杂志 Pub Date : 2006-01-01 DOI: 10.1177/15266028060130s106

A. Lumsden, T. Rice

{"title":"Medical management of peripheral arterial disease: a therapeutic algorithm.","authors":"A. Lumsden, T. Rice","doi":"10.1177/15266028060130s106","DOIUrl":"https://doi.org/10.1177/15266028060130s106","url":null,"abstract":"Over half of the people with peripheral arterial disease (PAD) may be asymptomatic. The most common symptom of mild-to-moderate PAD is intermittent claudication, present in about one third of symptomatic patients. Patients with intermittent claudication often have severely impaired functional status. Despite the high prevalence of the disease and the strong association with cardiovascular morbidity and mortality, patients with PAD are less likely to receive appropriate treatment for their atherosclerotic risk factors than are those being treated for coronary artery disease. The goals of treatment are to prevent progression of systemic atherosclerosis and its associated morbidity and mortality, to prevent limb loss, and to improve functional capacity for symptomatic patients. For claudicating patients, medical management includes symptomatic treatment with cilostazol or pentoxifylline. For all patients, it is equally important to pursue risk reduction through exercise programs and promotion of smoking cessation, as well as with the use of statins, antiplatelet therapies, antithrombotic strategies, angiotensin-converting-enzyme inhibitors, beta-blockers, and attention to homocysteine levels. Because not all patients are symptomatic, medical management of peripheral arterial disease may proceed along an algorithmic pathway that recognizes 3 types of patients: those requiring risk reduction only, symptomatic patients with minimal lifestyle limitation, and symptomatic patients with significant lifestyle impairment.","PeriodicalId":60152,"journal":{"name":"血管与腔内血管外科杂志","volume":"20 1","pages":"II19-29"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91117219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 11

Carotid artery stenting in octogenarians: the jury is still out. 颈动脉支架置入术在八十多岁老人中的应用:尚无定论。

血管与腔内血管外科杂志 Pub Date : 2006-01-01 DOI: 10.1583/06-1836c.1

R. Hobson

引用次数: 0

Advances in vascular brachytherapy over the last 10 years: focus on femoropopliteal applications. 近10年来血管近距离放射治疗的进展:聚焦于股腘动脉的应用。

血管与腔内血管外科杂志 Pub Date : 2004-12-01 DOI: 10.1583/04-1298.1

M. Schillinger, E. Minar

引用次数: 5